These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27790844)

  • 1. A next-generation anti-IgE monoclonal?
    Roberts G
    Clin Exp Allergy; 2016 Nov; 46(11):1370-1371. PubMed ID: 27790844
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-IgE treatment in allergic rhinitis.
    Bayar Muluk N; Bafaqeeh SA; Cingi C
    Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109674. PubMed ID: 31526939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
    Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
    J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
    D'Amato G; Oldani V; Donner CF
    Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of monoclonal antibody omalizumab in the treatment of allergic rhinitis].
    Qiu X; Wang H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Feb; 50(2):166-8. PubMed ID: 25916543
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of omalizumab therapy on allergic rhinitis: a pilot study.
    Masieri S; Cavaliere C; Begvarfaj E; Rosati D; Minni A
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5249-5255. PubMed ID: 28051241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab (Xolair): an anti-IgE antibody for asthma.
    Med Lett Drugs Ther; 2003 Aug; 45(1163):67-8. PubMed ID: 12915804
    [No Abstract]   [Full Text] [Related]  

  • 9. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
    Humbert M; Bousquet J; Bachert C; Palomares O; Pfister P; Kottakis I; Jaumont X; Thomsen SF; Papadopoulos NG
    J Allergy Clin Immunol Pract; 2019; 7(5):1418-1429. PubMed ID: 30928481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.
    Kim DH; Park KY; Kim BJ; Kim MN; Mun SK
    Clin Exp Dermatol; 2013 Jul; 38(5):496-500. PubMed ID: 23083013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab and the immune system: an overview of preclinical and clinical data.
    Johansson SG; Haahtela T; O'Byrne PM
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):132-8. PubMed ID: 12197568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is new in antiimmunoglobulin E asthma therapy.
    Berger WE
    Allergy Asthma Proc; 2005; 26(6):428-34. PubMed ID: 16541964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden.
    Dewilde S; Turk F; Tambour M; Sandström T
    Curr Med Res Opin; 2006 Sep; 22(9):1765-76. PubMed ID: 16968580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric allergic rhinitis.
    Tharpe CA; Kemp SF
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):185-98. PubMed ID: 25459584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab in asthma: approval and postapproval experience.
    Chiang DT; Clark J; Casale TB
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):3-16. PubMed ID: 16222080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab for the Treatment of Multiple Food Allergies. Reply.
    Wood RA; Togias A; Chinthrajah RS
    N Engl J Med; 2024 May; 390(20):1936. PubMed ID: 38810198
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of allergic rhinitis and other immunoglobulin E-mediated diseases with anti-immunoglobulin E antibody.
    Berger WE
    Allergy Asthma Proc; 2006; 27(2 Suppl 1):S29-32. PubMed ID: 16722329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma.
    Lambert N; Guiddir T; Amat F; Just J
    Pediatr Allergy Immunol; 2014 Dec; 25(8):829-32. PubMed ID: 25387446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.